NCBI PubMed Central
open access
Sodium Glucose Co-Transporter-2 inhibitors in patients with systemic sclerosis with or without heart failure.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Hemodynamic Effects of SGLT2i in Acute Decompensated Heart Failure#846269
- Cardiac Safe Transplants for Systemic Sclerosis#810251
- Investigation of Coronary and Pulmonary Circulatory Parameters in Systemic Sclerosis#369893
- Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers#405369
- Seoul National University Hospital Systemic Sclerosis Cohort#141140
Record · ID 295501
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive